Biosimilars Market size was valued at USD 25.10 Billion in 2022 and is expected to reach USD 91.81 Billion By 2030 and grow at a CAGR of 17.6% over the forecast period of 2023-2030. This impressive surge is driven by a confluence of factors, including: Significant cost savings: Biosimilars, highly similar versions of existing biologic drugs, offer substantial cost reductions...

The Insulin Pump Market was valued at USD 4.40 Billion in 2022 and is expected to reach USD 14.82 Billion By 2030 and grow at a CAGR of 16.4% over the forecast period of 2023-2030. This impressive surge is driven by a confluence of factors, including: Rising diabetes prevalence: The global burden of diabetes is steadily increasing, particularly type 1 diabetes, creating a...